Pharbest Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Pharbest Pharmaceuticals's estimated annual revenue is currently $7.6M per year.
- Pharbest Pharmaceuticals's estimated revenue per employee is $231,455
Employee Data
- Pharbest Pharmaceuticals has 33 Employees.
- Pharbest Pharmaceuticals grew their employee count by 6% last year.
Pharbest Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Procurement and Inventory Manager | Reveal Email/Phone |
2 | Inventory Manager and Account Specialist | Reveal Email/Phone |
3 | QA Manager | Reveal Email/Phone |
4 | Product Development and Product Management Incharge | Reveal Email/Phone |
5 | Market Research and Business Development Associate | Reveal Email/Phone |
6 | Marketing Associate | Reveal Email/Phone |
Pharbest Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.3M | 54 | 8% | N/A | N/A |
#2 | $354.3M | 461 | -2% | $567.1M | N/A |
#3 | $377.1M | 1427 | -8% | N/A | N/A |
#4 | $7.8M | 36 | 13% | N/A | N/A |
#5 | $5.4M | 25 | 14% | N/A | N/A |
#6 | $45M | 192 | 4% | N/A | N/A |
#7 | $6.8M | 27 | -4% | N/A | N/A |
#8 | $9.2M | 46 | 12% | N/A | N/A |
#9 | N/A | 694 | 46% | N/A | N/A |
#10 | $15.5M | 50 | -22% | N/A | N/A |
What Is Pharbest Pharmaceuticals?
OTC/GENERIC manufacturer specializing in production and packaging of OTC and NEUTRACEUTICAL finished products such as Regular Aspirin, Low-Dose Aspirin, Enteric Coated Aspirin, Acetaminophen, Diphenhydramine, Oyster Shell Calcium, Senna, Docusate Sodium Soft gelatin capsule, Ibuprofen, Calcium Carbonate, Vitamin C...etc.
keywords:N/AN/A
Total Funding
33
Number of Employees
$7.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.9M | 33 | -3% | N/A |
#2 | $2.7M | 33 | 27% | N/A |
#3 | $6.9M | 33 | 10% | N/A |
#4 | $14.4M | 34 | -6% | N/A |
#5 | $10.2M | 35 | -10% | N/A |